The notion that, in A*01:01 carriers, the majority of the CD8+ T cell response are focused on nonstructural proteins provides the rationale for designing vaccines that contain immunodominant peptides from proteins besides S. Moreover, it was recently shown that T cell response to early expressed nonstructural proteins may result in protection from the symptomatic infection (32). This evidence concerns the gene CD8A and infection.